Novartis AG ADR sell The Goldman Sachs Group, Inc.
Start price
12.09.25
/
50%
€106.50
Target price
12.09.26
€100.61
Performance (%)
6.10%
Price
17:07
€113.00
Summary
This prediction is currently active. With a performance of 6.10%, the SELL prediction by The_Goldman_Sachs_Gr for Novartis AG ADR is trending in the wrong direction This prediction currently runs until 12.09.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Novartis AG ADR | -1.322% | -1.322% |
iShares Core DAX® | -2.465% | 2.641% |
iShares Nasdaq 100 | -2.812% | 3.120% |
iShares Nikkei 225® | -0.345% | 6.386% |
iShares S&P 500 | -2.640% | 1.894% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Novartis AG ADR diskutieren
Novartis (NYSE:NVS) had its "sell" rating reaffirmed by analysts at The Goldman Sachs Group, Inc.. They now have a $118.00 price target on the stock, down previously from $119.00.
Ratings data for NVS provided by MarketBeat